MedTrace Logo

Brain Outcome After Cardiac Arrest - Intervention

NCT05133869 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2024-01-24

No results posted yet for this study

Summary

People who suffered a cardiac arrest are often have cognitive impairments. In this study the investigators test the effectiveness of an intervention, combining direct training and metacognitive training, in a single case experimental design (SCED).

Conditions

Interventions

DEVICE

Metacognitive training + direct training

The intervention will consist of a combination of direct training of the impaired cognitive function(s) and metacognitive strategy training for 42 days (6 weeks). Direct training will be done with the computer program Rehacom for 20 minutes, 5 times a week. Metacognitive strategy training will be given on a weekly or biweekly basis (6-10 sessions) by a trained therapist at Adelante. Rehacom is a brain training program developed to improve a variety of cognitive functions with the use of game-like cognitive training modules. During the intervention the participant should train with Rehacom for approximately 600 minutes in total. In addition to the direct training, the participant receives six to ten sessions of metacognitive strategy training. During this training they are taught strategies by a therapist to improve their performance on the Rehacom modules and on daily life functioning. Each metacognitive strategy is linked to one of the Rehacom modules.

Sponsors & Collaborators

  • Rijnstate Hospital

    collaborator OTHER

  • Adelante, Centre of Expertise in Rehabilitation and Audiology

    collaborator OTHER

  • Maastricht University Medical Center

    collaborator OTHER

  • Maastricht University

    lead OTHER

Principal Investigators

  • Caroline van Heugten, prof · Maastricht University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-21
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05133869 on ClinicalTrials.gov